These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 35538834)
1. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma. Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834 [TBL] [Abstract][Full Text] [Related]
2. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analyses proposed xenotropic and polytropic retrovirus receptor 1 as a potential diagnostic and prognostic biomarker and immunotherapeutic target in head and neck squamous cell carcinoma. Wang L Auris Nasus Larynx; 2023 Feb; 50(1):134-150. PubMed ID: 35690506 [TBL] [Abstract][Full Text] [Related]
5. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma. Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463 [TBL] [Abstract][Full Text] [Related]
6. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682 [TBL] [Abstract][Full Text] [Related]
7. CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma. Zhang Z; Ren X; Wang Y; Liu P; Lin P; Jin S; Xu C BMC Oral Health; 2024 Jun; 24(1):742. PubMed ID: 38937712 [TBL] [Abstract][Full Text] [Related]
8. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of TPD52L2 in HNSCC: prognostic significance and correlation with immune infiltrates. Lu M; Xia H; Xu J; Liao Z; Li Y; Peng H BMC Oral Health; 2024 Oct; 24(1):1191. PubMed ID: 39375696 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma. Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786 [TBL] [Abstract][Full Text] [Related]
12. FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis. Dong QT; Ma DD; Gong Q; Lin ZY; Li ZH; Ye JX; Qin CH; Jin WD; Zhang JX; Zhang ZY Sci Rep; 2023 Sep; 13(1):15144. PubMed ID: 37704682 [TBL] [Abstract][Full Text] [Related]
13. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma. He J; Ouyang S; Zhao Y; Liu Y; Liu Y; Zhou B; Man Q; Liu B; Wu T Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830672 [TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma. Jung AR; Jung CH; Noh JK; Lee YC; Eun YG Sci Rep; 2020 Feb; 10(1):3652. PubMed ID: 32107458 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma. Wu CC; Xiao Y; Li H; Mao L; Deng WW; Yu GT; Zhang WF; Sun ZJ Pathol Res Pract; 2019 Apr; 215(4):772-778. PubMed ID: 30683473 [TBL] [Abstract][Full Text] [Related]
17. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
18. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma. Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y PeerJ; 2023; 11():e16237. PubMed ID: 37842043 [TBL] [Abstract][Full Text] [Related]
19. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
20. Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma. Yang ZM; Liao B; Yang SS; Su T; Zhang J; Wang WM Front Endocrinol (Lausanne); 2022; 13():943686. PubMed ID: 35898455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]